IHC-plus™ c-Met Antibody (Cytoplasmic Domain)

Catalogue Number: LS-B2812-LSP

Manufacturer:LifeSpan BioSciences Inc.
Preservative:0.09% Sodium azide
Type:Monoclonal Primary Antibody - Unconjugated
Alias:MET, AUTS9, C-Met, HGF/SF receptor, HGFR, Met kinase, Proto-oncogene c-Met, Scatter factor receptor, SF receptor, HGF receptor, RCCP2, Tyrosine-protein kinase Met
Shipping Condition:RT
Unit(s): 50 ul
Host name: Mouse
Clone:
Isotype: IgG2a
Immunogen: Synthetic peptide derived from cytoplasmic domain of human c-Met protein
Application: IHC-P, IHC-Fr, IHC

Additional Text

Gene ID

4233

Gene Name

MET

Antigen Type

Synthetic Peptide

Concentration

1.14 mg/ml

Purification

Purified

Storage Note

Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.

Antibody Clonality

Monoclonal

Short Description

C-Met antibody LS-B2812 is an unconjugated mouse monoclonal antibody to human c-Met (Cytoplasmic Domain). Validated for IHC. Tested on 20 paraffin-embedded human tissues. Cited in 3 publications.

Application Notes

Immunohistochemistry: LS-B2812 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2812 was determined to be 10 ug/ml. Positive control: Breast cancer.